Your browser doesn't support javascript.
loading
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto, Paolo; Tessema, Belay; Tagliani, Elisa; Chindelevitch, Leonid; Starks, Angela M; Emerson, Claudia; Hanna, Debra; Kim, Peter S; Liwski, Richard; Zignol, Matteo; Gilpin, Christopher; Niemann, Stefan; Denkinger, Claudia M; Fleming, Joy; Warren, Robin M; Crook, Derrick; Posey, James; Gagneux, Sebastien; Hoffner, Sven; Rodrigues, Camilla; Comas, Iñaki; Engelthaler, David M; Murray, Megan; Alland, David; Rigouts, Leen; Lange, Christoph; Dheda, Keertan; Hasan, Rumina; Ranganathan, Uma Devi K; McNerney, Ruth; Ezewudo, Matthew; Cirillo, Daniela M; Schito, Marco; Köser, Claudio U; Rodwell, Timothy C.
Afiliação
  • Miotto P; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy miotto.paolo@hsr.it.
  • Tessema B; Department of Medical Microbiology, University of Gondar, Gondar, Ethiopia.
  • Tagliani E; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Chindelevitch L; School of Computing Science, Simon Fraser University, Burnaby, BC, Canada.
  • Starks AM; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Emerson C; Institute on Ethics & Policy for Innovation, Department of Philosophy, McMaster University, Hamilton, ON, Canada.
  • Hanna D; Critical Path Institute, Tucson, AZ, USA.
  • Kim PS; Office of AIDS Research, National Institutes of Health, Rockville, MD, USA.
  • Liwski R; Critical Path Institute, Tucson, AZ, USA.
  • Zignol M; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
  • Gilpin C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
  • Niemann S; Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany.
  • Denkinger CM; German Center for Infection Research, Borstel, Germany.
  • Fleming J; Foundation for Innovative New Diagnostics, Campus Biotech, Geneva, Switzerland.
  • Warren RM; Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Crook D; DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
  • Posey J; Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Gagneux S; National Infection Service, Public Health England, London, UK.
  • Hoffner S; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Rodrigues C; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Comas I; University of Basel, Basel, Switzerland.
  • Engelthaler DM; Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Murray M; Public Health Agency of Sweden, Solna, Sweden.
  • Alland D; Hinduja Hospital, Veer Savarkar Marg, Mumbai, India.
  • Rigouts L; Tuberculosis Genomics Unit, Biomedicine Institute of Valencia (IBV-CSIC), Valencia, Spain.
  • Lange C; Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain.
  • Dheda K; CIBER (Centros de Investigación Biomédica en Red) in Epidemiology and Public Health, Madrid, Spain.
  • Hasan R; Translational Genomics Research Institute, Flagstaff, AZ, USA.
  • Ranganathan UDK; Harvard School of Public Health, Department of Epidemiology, Boston, MA, USA.
  • McNerney R; Center for Emerging Pathogens, Rutgers-New Jersey Medical School, Newark, NJ, USA.
  • Ezewudo M; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Cirillo DM; Division of Clinical Infectious Diseases and German Center for Infection Research Tuberculosis Unit, Research Center Borstel, Borstel, Germany.
  • Schito M; International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
  • Köser CU; Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Rodwell TC; Department of Internal Medicine, University of Namibia School of Medicine, Windhoek, Namibia.
Eur Respir J ; 50(6)2017 12.
Article em En | MEDLINE | ID: mdl-29284687
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interpretação Estatística de Dados / Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interpretação Estatística de Dados / Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article